Business Context and Reporting Period
This Form 8-K Current Report was filed by Cocrystal Pharma, Inc. on January 7, 2019, covering events that occurred on January 4, 2019. The filing addresses significant changes to the Company's Board of Directors and executive leadership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignations: Dr. Raymond F. Schinazi (Chairman) and Dr. David Block (Director) resigned from the Board. Dr. Block's resignation was effective immediately. Dr. Schinazi's resignation is effective February 1, 2019.
- Appointments: Dr. Gary Wilcox was appointed Chief Executive Officer (effective immediately) and Chairman of the Board (effective February 1, 2019). He previously served as Interim CEO and Vice Chairman.
- Future Roles: Upon his resignation, Dr. Schinazi is expected to serve as a special advisor to the CEO and on the scientific advisory board, subject to academic affiliation approval.
- Reasoning: The resignations were not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. Management commentary is limited to the confirmation that the leadership changes were amicable and that there were no changes to Dr. Wilcox's compensation arrangements.
Investor Verification Checklist
- Verify the effective dates of the Board resignations and new appointments (January 4 vs. February 1, 2019).
- Confirm Dr. Schinazi's transition to a special advisor role and his continued involvement with the scientific advisory board.
- Review the Company's prior Schedule 14A Proxy Statement (filed June 25, 2018) for Dr. Wilcox's full biographical information and compensation details.
- Monitor subsequent filings for the appointment of new directors to fill the vacancies left by Dr. Schinazi and Dr. Block.